WATERTOWN, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel ...
NX-5948 has received fast track designation for relapsed or refractory Waldenström macroglobulinemia after prior BTK inhibitor therapy. The phase 1a/1b trial of NX-5948 shows a 77.8% objective ...
Nearly 20 years ago, scientists stunned the world when they announced they had decoded the genes that make up a human being. As we first reported last March, they hoped to use that genetic blueprint ...
GREENVILLE, S.C. (WSPA)—31 million Americans live with anemia, according to the Centers for Disease Control, but what is it?
The novel treatment elritercept received a Fast Track designation from the FDA to treat anemia in patients with MDS. For patients with lower-risk myelodysplastic syndromes (MDS), the Food and Drug ...
The FDA is reviewing a drug that could cure sickle cell anemia. Right now bone marrow or stem cell transplants are the only FDA-approved cures. The Food and Drug Administration says there’s an unmet ...
Stanford Medicine pediatric hematologist Agnieszka Czechowicz, MD, Ph.D., has devoted her research career to improving ...
Dr Sandip Shah said aplastic anemia can affect anyone, but is more common in younger adults. Symptoms include fatigue, shortness of breath and bleeding.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results